| Cat. No. |
Product Name |
Information |
| PC-45245 |
Abacavir sulfate
NRTI
|
Abacavir sulfate is a nucleoside reverse transcriptase inhibitor (NRTI) that used to prevent and treat HIV/AIDS. |
| PC-45244 |
Abacavir
NRTI
|
Abacavir is a nucleoside reverse transcriptase inhibitor (NRTI) that used to prevent and treat HIV/AIDS. |
| PC-45235 |
Zidovudine
NRTI
|
Zidovudine (Azidothymidine;AZT;ZDV) is a nucleoside reverse transcriptase inhibitor (NRTI) that used to prevent and treat HIV/AIDS. |
| PC-45250 |
Emtricitabine
NRTI
|
Emtricitabine (BW-1592) is a nucleoside reverse transcriptase inhibitor (NRTI) for the prevention and treatment of HIV infection, also exhibits clinical activity against the hepatitis B virus (HBV). |
| PC-45074 |
Doravirine
NNRTI
|
Doravirine (MK-1439, MK1439) is a novel, highly specific HIV-1 nonnucleoside reverse transcriptase inhibitor (NNRTI) with IC50 of 12, 9.7, and 9.7 nM against WT, K103N, and Y181C reverse transcriptase (RT) mutants, respectively, in a biochemical assay. |
| PC-42661 |
Rilpivirine
NNRTI
|
Rilpivirine (R278474, TMC278) is a highly potent nonnucleoside inhibitor (NNRTI) of HIV-1 reverse trK7912:M7912anscriptase with IC50 of 0.4 nM for WT HIV-1 in cell-based assay. |
| PC-42660 |
Efavirenz
NNRTI
|
Efavirenz (DMP 266, EFV) is a highly potent nonnucleoside inhibitor (NNRTI) of HIV-1 reverse transcriptase with Ki of 2.93 nM for WT HIV-1 RT. |
| PC-45186 |
Atazanavir
HIV-1 protease inhibitor
|
Atazanavir (BMS-232632) is a highly potent HIV-1 protease inhibitor that exhibits potent anti-HIV activity EC50 of 2.6-5.3 nM and EC90 of 9-15 nM in cell culture. |
| PC-42793 |
BMS-538203
|
BMS-538203 is a chemical intermidate of BMS-626529, a HIV-1 attachment inhibitor that targets gp120. |
| PC-23582 |
Dapivirine
NNRTI
|
Dapivirine (TMC120, R147681) is a potent, HIV-1 nonnucleoside reverse transcriptase inhibitor (NNRTI) with IC50 of 24 nM, inhibits syncytium formation of HIV-1 IIIB-infected CEM T cells with EC50 of 1 nM, shows high activity against wild-type and mutant HIV. |
| PC-23258 |
VH3739937
HIV-1 maturation inhibitor
|
VH3739937 (GSK3739937, VH-937) is a potent, specific HIV-1 maturation inhibitor with EC50 of 1.8 nM against NLRepRlucP373S reporter virus. |
| PC-23160 |
DMJ-II-121
HIV-1 inhibitor
|
DMJ-II-121 is a small molecule inhibitor of HIV-1 envelope glycoprotein gp120, blocks CD4 binding, and inhibits HIV-1 infection. |
